Transaction overview
Incline Equity Partners has completed a continuation vehicle transaction for Accredited Labs, valued at approximately $300 million, on October 21, 2025. The Dallas-based company provides calibration and repair services for mission-critical test and measurement equipment across highly regulated sectors such as life sciences, aerospace, semiconductor manufacturing, and general industry.
Deal structure and financing
Incline Equity Partners raised significant capital to support the continuation vehicle transaction, with commitments totaling $300 million. This includes notable participation from Incline’s partners and employees, underscoring their alignment and confidence in Accredited Labs' future prospects. Specific details regarding equity versus debt composition or lock-up terms have not been disclosed publicly.
Strategic context
The continuation vehicle is intended to enable continued growth for Accredited Labs following the initial investment by Incline Equity Partners in 2023. Since then, Accredited Labs has executed a series of acquisitions that significantly increased its service capacity and geographic reach, diversifying its customer base across several non-discretionary markets. This strategic move allows Incline to maintain ownership while providing necessary capital for future expansion and M&A activities.
Regulatory path
No specific regulatory review or approval details have been made public concerning the continuation vehicle transaction involving Accredited Labs. Given the deal’s size and nature, it is likely that the Securities and Exchange Commission (SEC) was involved in overseeing the process due to its private equity context. However, no other regulatory bodies are known to have reviewed this particular transaction.
The continuation vehicle structure facilitated by Incline Equity Partners aims to support Accredited Labs’ strategic growth plans while aligning investor interests through substantial internal investment participation.